ISSN: 2155-9880
+44 1300 500008
Pietro Delise
In the clinical setting, drug testing is currently used to unmask a concealed Brugada Syndrome (BrS) both in patients with unexplained syncope and also in asymptomatic subjects with only suspect ECG signs. Recent studies, however, suggest that the induction of a Brugada type 1 ECG (Br type 1 ECG) by drugs may be an aspecific and/or a by-stander ECG sign. This is no idle hypothesis, as in clinical practice drug-induced Br type 1 ECG and BrS are often used as synonyms, feeding worldwide terror of this disease and resulting in an excess of inappropriate aggressive therapies in otherwise healthy subjects.
Condensed abstract: Drug testing is currently used to unmask a concealed Brugada Syndrome in patients with unexplained syncope and also in asymptomatic subjects with suspect ECG signs. Recent studies, however, suggest that the induction of a Brugada type 1 ECG by drugs may be an aspecific and/or a by-stander ECG sign.
Published Date: 2019-12-09; Received Date: 2019-11-18